<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-147467" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Antimony Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Martin</surname>
            <given-names>Rachel</given-names>
          </name>
          <aff>West Virginia University School of Medicine, Morgantown, WV</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lee</surname>
            <given-names>Vincent R.</given-names>
          </name>
          <aff>Northwell Health/Zucker School of Medicine at Hofstra School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rachel Martin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vincent Lee declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>9</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-147467.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Antimony (Sb) is an elemental metalloid chemically similar to arsenic.&#x000a0;Antimony's&#x000a0;use dates back to Chaldean times based on artifacts found in explorations.<xref ref-type="bibr" rid="article-147467.r1">[1]</xref>&#x000a0;Asian and Middle Eastern countries used antimony in cosmetics; antimony was later replaced with lead due to scarcity.<xref ref-type="bibr" rid="article-147467.r2">[2]</xref>&#x000a0;Topical forms of antimony were used to treat herpes, leprosy, mania, and epilepsy, while oral antimony potassium tartrate, also known as tartar emetic, was utilized for fever, pneumonia, congestion, inflammation, and sedation.<xref ref-type="bibr" rid="article-147467.r3">[3]</xref><xref ref-type="bibr" rid="article-147467.r4">[4]</xref><xref ref-type="bibr" rid="article-147467.r5">[5]</xref>&#x000a0;Antimony usage was eventually halted due to observed toxicity.</p>
        <p>Today, antimony is primarily medically used for treating leishmaniasis and schistosomiasis, as well as aversive treatment for substance use.<xref ref-type="bibr" rid="article-147467.r6">[6]</xref><xref ref-type="bibr" rid="article-147467.r7">[7]</xref> The mechanism of action is the inhibition of trypanothione reductase, a parasitic enzyme involved in protection against oxidative stress.<xref ref-type="bibr" rid="article-147467.r8">[8]</xref> Typically, pentavalent antimony compounds, such as meglumine antimoniate and sodium stibogluconate, are used as they offer superior tolerance to their trivalent counterparts, are efficient, and are cost-effective.<xref ref-type="bibr" rid="article-147467.r9">[9]</xref> Elemental antimony is not commonly used for industrial purposes due to its low malleability and is typically found in alloys with copper, lead, and tin. Antimony compounds can be used for a number of purposes, including the production of textiles, enamels, ceramics, pigments, and fireworks, as well as serving as catalysts for chemical reactions. Antimony compounds, particularly antimony trioxide and antimony oxychloride, are used in flame retardants.<xref ref-type="bibr" rid="article-147467.r1">[1]</xref><xref ref-type="bibr" rid="article-147467.r10">[10]</xref></p>
        <p>Elemental antimony is rare due to its rapid conversion to antimony oxide or antimony trioxide. Antimony naturally occurs in minerals, most prominently in the form of stibnite.<xref ref-type="bibr" rid="article-147467.r11">[11]</xref> Antimony may form compounds in its trivalent (Sb<sup>3+</sup>) state in antimony potassium tartrate, antimony trichloride, antimony trioxide, antimony trisulfide, and sibine, or in its pentavalent (Sb<sup>5+</sup>) state in antimony pentasulfide, antimony pentoxide, and antimony pentachloride. Antimony is found in high concentrations in the soil near firing ranges and mines.&#x000a0;Antimony&#x000a0;can pose a public health concern when found in water and other commercially produced food products due to manufacturing flaws or leaching from materials used for packaging.<xref ref-type="bibr" rid="article-147467.r12">[12]</xref><xref ref-type="bibr" rid="article-147467.r13">[13]</xref><xref ref-type="bibr" rid="article-147467.r14">[14]</xref><xref ref-type="bibr" rid="article-147467.r15">[15]</xref><xref ref-type="bibr" rid="article-147467.r16">[16]</xref></p>
        <p>Perhaps the most toxic antimony compound is stibine (SbH<sub>3</sub>), which closely resembles arsine (AsH<sub>3</sub>). Stibine is a malodorous colorless gas associated with lead storage battery charging.<xref ref-type="bibr" rid="article-147467.r17">[17]</xref>&#x000a0;Stibine can also be produced when using sodium hydroxide-based drain cleaners in the presence of antimony.<xref ref-type="bibr" rid="article-147467.r18">[18]</xref></p>
      </sec>
      <sec id="article-147467.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Exposure and toxicity typically occur through inhaling dust particles or fumes containing antimony. Electronic waste recycling workers have significant exposure to antimony, as do smelters; antimony is often found in ore containing arsenic, and coexposure is common.<xref ref-type="bibr" rid="article-147467.r19">[19]</xref><xref ref-type="bibr" rid="article-147467.r20">[20]</xref>&#x000a0;Antimony is often present in urine samples of refinery workers, chemical manufacturers, and battery manufacturers.<xref ref-type="bibr" rid="article-147467.r11">[11]</xref></p>
        <p>Stibine exposure is prevalent in the process of charging batteries.<xref ref-type="bibr" rid="article-147467.r3">[3]</xref>&#x000a0;Stibine is formed from antimony and hydrogen. Antimony can also be found in cigarette smoke; toxicity is more likely in smokers.<xref ref-type="bibr" rid="article-147467.r21">[21]</xref>&#x000a0; Maintenance workers are advised to avoid using drain cleaners containing sodium hydroxide, which is capable of releasing hydrogen ions in situations where antimony is present.<xref ref-type="bibr" rid="article-147467.r18">[18]</xref></p>
        <p>Although toxicity is generally associated with occupational exposure, people living near sources of antimony may be exposed via air, soil, and vegetation. The general population may also be exposed secondary to ingestion of food, water, or contaminated soil or dust.<xref ref-type="bibr" rid="article-147467.r11">[11]</xref>&#x000a0;Antimony toxicity can be seen with the use of medicinal antimonial compounds infrequently used in high-resource countries; medical professionals may be unfamiliar with dosing and administration guidelines. Acute antimony overdose is rare and typically is secondary to alcohol aversion treatment.<xref ref-type="bibr" rid="article-147467.r6">[6]</xref></p>
      </sec>
      <sec id="article-147467.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Antimony toxicity is rare and may be underreported and underdiagnosed. Results from a study conducted by the National Institute for Occupational Safety and Health&#x000a0;between 1981 and 1983 estimated that 486,347 workers were exposed to antimony and its various compounds. The frequency, concentration, and duration of exposure were not reported. Reported urinary antimony levels in battery workers were 5 times higher than other workers. In China, the highest levels of hair antimony levels were present in people involved in electronic waste recycling.<xref ref-type="bibr" rid="article-147467.r11">[11]</xref></p>
        <p>Studies comparing antimony toxicity in children to adults are not available. Rat studies have suggested that antimony may be transferred transplacentally and through breast milk. Plasma antimony levels in children following weight-based intramuscular meglumine antimoniate for leishmaniasis were statistically lower compared to adult counterparts, with a statistically significant shorter half-life in children.<xref ref-type="bibr" rid="article-147467.r11">[11]</xref></p>
      </sec>
      <sec id="article-147467.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Antimony toxicity can be subtle, especially in cases of chronic toxicity; the clinical presentation is variable. The most common presenting sign or symptom is localized irritation&#x000a0;that correlates to the concentration of antimony exposure. Ophthalmic exposure to antimony pentoxide can cause caustic injury, corneal burns, optic atrophy, uveitis, and retinal hemorrhage that may be permanent.<xref ref-type="bibr" rid="article-147467.r22">[22]</xref></p>
        <p>Gastrointestinal manifestations of antimony toxicity are also very common; typical symptoms include nausea, vomiting, and abdominal pain.<xref ref-type="bibr" rid="article-147467.r6">[6]</xref><xref ref-type="bibr" rid="article-147467.r23">[23]</xref> Antimony pentachloride reacts with water in saliva to produce hydrochloric acid, heat, and antimony pentoxide. The hydrochloric acid produced in this reaction can lead to gastrointestinal burns; severe overdoses may result in hemorrhagic gastritis. Treatment of pentavalent antimonial compounds such as meglumine antimoniate and sodium stibogluconate may lead to pancreatitis, especially in patients with HIV.<xref ref-type="bibr" rid="article-147467.r24">[24]</xref><xref ref-type="bibr" rid="article-147467.r25">[25]</xref><xref ref-type="bibr" rid="article-147467.r26">[26]</xref>&#x000a0;</p>
        <p>Antimony compounds&#x000a0;decrease cardiac contraction and lower vasomotor tone, resulting in lower systolic pressure and bradycardia.<xref ref-type="bibr" rid="article-147467.r3">[3]</xref><xref ref-type="bibr" rid="article-147467.r27">[27]</xref>&#x000a0;Pentavalent antimonial compounds, including sodium stibogluconate and meglumine antimoniate, can lead to QT prolongation, torsades de pointes, ST-segment changes, and T-wave abnormalities by increasing cardiac calcium currents and subsequent action potential prolongation.<xref ref-type="bibr" rid="article-147467.r28">[28]</xref><xref ref-type="bibr" rid="article-147467.r29">[29]</xref><xref ref-type="bibr" rid="article-147467.r30">[30]</xref><xref ref-type="bibr" rid="article-147467.r31">[31]</xref>&#x000a0;These changes are more likely in patients with underlying cardiac disease.<xref ref-type="bibr" rid="article-147467.r32">[32]</xref> Meglumine antimoniate is associated with an increased risk of pericarditis.<xref ref-type="bibr" rid="article-147467.r33">[33]</xref> Antimony compounds may also be associated with cardiomyopathy.<xref ref-type="bibr" rid="article-147467.r34">[34]</xref>&#x000a0;Additionally, data obtained from the National Health and Nutrition Examination Survey (NHANES) has suggested a positive correlation between antimony exposure in combination with other metals and the risk of cardiovascular disease.<xref ref-type="bibr" rid="article-147467.r35">[35]</xref></p>
        <p>Local respiratory tract irritation can lead to pneumonitis, tracheitis, and laryngitis, especially in exposure to antimony trioxide.<xref ref-type="bibr" rid="article-147467.r20">[20]</xref><xref ref-type="bibr" rid="article-147467.r36">[36]</xref>&#x000a0;Cases of acute respiratory distress syndrome have been described following acute antimony pentachloride exposure.<xref ref-type="bibr" rid="article-147467.r37">[37]</xref> Chronic exposure is associated with &#x0201c;antimony pneumoconiosis&#x0201d; which may progress to chronic obstructive pulmonary disease.<xref ref-type="bibr" rid="article-147467.r38">[38]</xref> Radiographic manifestations may yield&#x000a0;multiple small opacities with a predominant distribution in the middle and lower lung fields.<xref ref-type="bibr" rid="article-147467.r39">[39]</xref></p>
        <p>Antimony compounds may cause nephrotoxicity. Sodium stibogluconate exposure can lead to acute kidney injury, renal tubular acidosis with subsequent hyperchloremic metabolic acidosis, and acute tubular injury, especially in older patients and those with chronic kidney disease.<xref ref-type="bibr" rid="article-147467.r40">[40]</xref><xref ref-type="bibr" rid="article-147467.r41">[41]</xref><xref ref-type="bibr" rid="article-147467.r42">[42]</xref><xref ref-type="bibr" rid="article-147467.r43">[43]</xref>&#x000a0;Antimony exposure may also lead to drug-induced interstitial nephritis that typically responds to steroids.<xref ref-type="bibr" rid="article-147467.r44">[44]</xref> Severe stibine exposure may result in hematuria, rhabdomyolysis, and death.<xref ref-type="bibr" rid="article-147467.r45">[45]</xref></p>
        <p>Acute liver injury may be a result of acute antimony toxicity.<xref ref-type="bibr" rid="article-147467.r6">[6]</xref> Chronic antimony exposure may lead to hepatotoxicity, especially in older patients.<xref ref-type="bibr" rid="article-147467.r46">[46]</xref> Fulminant liver failure may be seen despite an initial response to therapy. The proposed injurious mechanism combines immunologic hepatic injury and direct antimony effect.<xref ref-type="bibr" rid="article-147467.r47">[47]</xref><xref ref-type="bibr" rid="article-147467.r48">[48]</xref> Ascorbic acid administration has been shown to provide hepatic protection.<xref ref-type="bibr" rid="article-147467.r49">[49]</xref></p>
        <p>Hematologic effects of antimony toxicity may also be seen. Sodium stibogluconate has been shown to cause severe anemia in patients who are HIV-positive, with resolution after drug cessation.<xref ref-type="bibr" rid="article-147467.r50">[50]</xref> Thrombocytopenia has also been seen with the use of sodium stibogluconate but may be secondary to pancytopenia induced by visceral leishmaniasis.<xref ref-type="bibr" rid="article-147467.r51">[51]</xref> Stibine exposure has a strong association with massive hemolysis; this is believed to be due to the fixation of stibine molecules to sulfhydryl groups of hemoglobin, leading to oxidative stress and erythrocyte injury, as seen in arsine toxicity.<xref ref-type="bibr" rid="article-147467.r52">[52]</xref></p>
        <p>Pentavalent antimony compounds can produce neurological manifestations. Sodium stibogluconate may lead to cerebellar ataxia and reversible peripheral neuropathy, while meglumine antimoniate may lead to vestibulocochlear toxicity with symptoms of tinnitus, increased auditory threshold, and rotatory dizziness.<xref ref-type="bibr" rid="article-147467.r53">[53]</xref><xref ref-type="bibr" rid="article-147467.r54">[54]</xref><xref ref-type="bibr" rid="article-147467.r55">[55]</xref>&#x000a0;Development of tremors, extrapyramidal symptoms, and generalized tonic-clonic seizures associated with the antimonial treatment of leishmaniasis have also been documented.<xref ref-type="bibr" rid="article-147467.r56">[56]</xref></p>
        <p>Antimony may be carcinogenic, with antimony trioxide labeled as a group 2B carcinogen.<xref ref-type="bibr" rid="article-147467.r57">[57]</xref>&#x000a0;Stibine and trimethylstibine are genotoxic, theoretically due to the generation of reactive oxygen species. Other antimony compounds, including potassium antimony tartrate, trimethylantimony dichloride, and potassium hexahydroxyantimonate are not carcinogenic.<xref ref-type="bibr" rid="article-147467.r17">[17]</xref> Trivalent antimony partially impairs&#x000a0;nucleotide excision repair, suggesting an&#x000a0;indirect mechanism of carcinogenesis.<xref ref-type="bibr" rid="article-147467.r57">[57]</xref> However, evidence of antimony-induced carcinogenesis&#x000a0;is inconclusive. Rat studies have shown an increase in pulmonary tumors in those exposed to antimony trioxide and antimony trisulfide.<xref ref-type="bibr" rid="article-147467.r58">[58]</xref>&#x000a0;Results from a human study showed an increased incidence of lung cancer in smelters compared to the unexposed population but did not account for other factors, including arsenic concomitant exposure and tobacco smoking.<xref ref-type="bibr" rid="article-147467.r59">[59]</xref>&#x000a0;Other data has failed to replicate this increased risk of lung cancer in exposed workers.<xref ref-type="bibr" rid="article-147467.r39">[39]</xref> There also has been an increased incidence of bladder tumors in patients being treated for leishmaniasis with potential attribution to antimonial compounds, with higher serum antimony concentrations being associated with a worse prognosis.<xref ref-type="bibr" rid="article-147467.r3">[3]</xref><xref ref-type="bibr" rid="article-147467.r60">[60]</xref>&#x000a0;In addition, it has been proposed that low-dose antimony exposure may promote the proliferation of prostate cancer by inhibiting ferroptosis.<xref ref-type="bibr" rid="article-147467.r61">[61]</xref></p>
      </sec>
      <sec id="article-147467.s5" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Antimony may be absorbed through inhalation, oral ingestion, or transdermally. Oral bioavailability is 15% to 50%, and gastrointestinal absorption begins rapidly after ingestion.<xref ref-type="bibr" rid="article-147467.r62">[62]</xref><xref ref-type="bibr" rid="article-147467.r63">[63]</xref>&#x000a0;The degree of inhalational absorption depends on the specific compound. Inorganic compounds are absorbed more slowly and have minimal water solubility. Trivalent compounds have higher levels of absorption.<xref ref-type="bibr" rid="article-147467.r64">[64]</xref></p>
        <p>The distribution of antimony is dependent on the oxidation state and route of administration. Trivalent antimony is typically bound to red blood cells, while pentavalent antimony tends to remain in serum.<xref ref-type="bibr" rid="article-147467.r11">[11]</xref> Orally or intravenously administered antimony is largely distributed to organs that are highly vascularized, including the liver, thyroid, adrenals, and kidneys&#x02014;with pentavalent forms being distributed primarily to the liver and spleen and trivalent forms being distributed mainly to the thyroid.<xref ref-type="bibr" rid="article-147467.r3">[3]</xref><xref ref-type="bibr" rid="article-147467.r11">[11]</xref><xref ref-type="bibr" rid="article-147467.r46">[46]</xref>&#x000a0;Inhaled antimony is primarily bound to red blood cells, with lower concentrations in the liver and spleen.<xref ref-type="bibr" rid="article-147467.r64">[64]</xref></p>
        <p>Metabolic conversions of antimony are limited in humans. Pentavalent antimony is converted to its trivalent form in the liver or acidic intracellular environments of cells infected with <italic toggle="yes">Leishmania.</italic><xref ref-type="bibr" rid="article-147467.r3">[3]</xref><xref ref-type="bibr" rid="article-147467.r65">[65]</xref>&#x000a0;Antimony may be transformed by forming covalent bonds with sulfhydryl or phosphate groups, being incorporated into lipid molecules, or binding to macromolecules.<xref ref-type="bibr" rid="article-147467.r11">[11]</xref>&#x000a0;The excretion of antimony also depends on the oxidative state. Trivalent antimony is conjugated with glutathione and excreted in the bile, with most undergoing enterohepatic recirculation and the residual being slowly eliminated by urine.<xref ref-type="bibr" rid="article-147467.r8">[8]</xref>&#x000a0;Pentavalent antimony is more quickly excreted in the urine.<xref ref-type="bibr" rid="article-147467.r3">[3]</xref></p>
      </sec>
      <sec id="article-147467.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>When obtaining a medical history from a patient with suspected antimony exposure, documenting the route of exposure is imperative. Duration and concentration of exposure, risk of coexposure or coingestion, and preexisting medical conditions such as renal disease, liver disease, cardiovascular disease, HIV, and tobacco use should be ascertained. In acute ingestions, suicidal and homicidal ideations should be addressed. The review of systems should include ocular irritation or pain, skin rash, nasopharyngeal irritation, epistaxis, anorexia, nausea, vomiting, diarrhea, hematemesis, melena, hematochezia, abdominal pain, respiratory difficulty or distress, cough, chest pain, palpitations, decreased urinary output, tinnitus, and vertigo.</p>
        <p>The physical examination findings of a patient with antiony toxicity are variable. Antimony toxicity primarily presents with local irritation. Patients may have skin findings of pustules and papules consistent with &#x0201c;antimony spots&#x0201d; developing around sebaceous and sweat glands.<xref ref-type="bibr" rid="article-147467.r66">[66]</xref> Chronic exposure may result in lichenification and eczema of the extremities and joint spaces, sparing the face, hands, and feet. Such findings typically occur in warmer summer months.<xref ref-type="bibr" rid="article-147467.r36">[36]</xref> In antimony hypersensitivity reactions, patients may have urticarial lesions, eczema, subcutaneous nodules, or symptoms of anaphylaxis, including wheezing and gastrointestinal distress. Rashes consistent with contact dermatitis may also occur.<xref ref-type="bibr" rid="article-147467.r67">[67]</xref> Patients may also have inflammation of the nasal and oropharyngeal cavities. Thrombophlebitis may be present.<xref ref-type="bibr" rid="article-147467.r23">[23]</xref>&#x000a0;Ocular findings may be present, including decreased visual acuity and ocular pain and irritation.<xref ref-type="bibr" rid="article-147467.r22">[22]</xref></p>
        <p>Patients may have abdominal tenderness, especially when accompanied by gastrointestinal symptoms, and may have a garlic-like odor on the breath, but this could be secondary to arsenic coexposure. In severe cases, gastrointestinal&#x000a0;hemorrhage may be present.<xref ref-type="bibr" rid="article-147467.r23">[23]</xref>&#x000a0;Cardiopulmonary auscultation may reveal an irregular rhythm, tachypnea, hypoxia, coarse breath sounds, or wheezing. In the presence of hepatic injury, patients may have jaundice, scleral icterus, ascites, or altered mental status. Hematologic manifestations may present with skin or conjunctival pallor, petechiae, purpura, or mucosal bleeding. Neurologically, patients may have peripheral neuropathy, nystagmus, and rotatory dizziness.<xref ref-type="bibr" rid="article-147467.r53">[53]</xref><xref ref-type="bibr" rid="article-147467.r55">[55]</xref></p>
      </sec>
      <sec id="article-147467.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>When evaluating suspected or known antimony toxicity, laboratory studies should include complete blood count, electrolyte levels, serum glucose, renal function studies, and urinalysis. In acute toxicity, assessment of volume depletion and renal injury should be prioritized. In the case of stibine exposure, bilirubin, serum lactate dehydrogenase, and haptoglobin should be added to evaluate for hemolysis; blood type and cross-matching should be obtained due to the high likelihood of blood transfusion.<xref ref-type="bibr" rid="article-147467.r52">[52]</xref></p>
        <p>An electrocardiogram should be obtained to assess for QT interval prolongation or dysthymias. Continuous cardiac monitoring is recommended.<xref ref-type="bibr" rid="article-147467.r32">[32]</xref> Chest radiography may be useful in patients with hypoxia or other respiratory symptoms.<xref ref-type="bibr" rid="article-147467.r39">[39]</xref> Abdominal imaging may be useful in patients with gastrointestinal symptoms.<xref ref-type="bibr" rid="article-147467.r68">[68]</xref> For caustic injuries, endoscopy may be indicated if the patient has stridor, drooling, or vomiting. Computed tomography imaging may be reasonable in suspected malignancy secondary to exposure. Most serum antimony levels are not typically processed in-house at most hospitals and thus are not helpful on initial evaluation. Normal antimony concentration in unexposed patients is less than 3 mcg/L.<xref ref-type="bibr" rid="article-147467.r69">[69]</xref> Urine antimony levels in a 24-hour collection may also be obtained, with normal levels less than 6.2 mcg/L.<xref ref-type="bibr" rid="article-147467.r70">[70]</xref></p>
      </sec>
      <sec id="article-147467.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>When antimony exposure is suspected or confirmed, consulting with a medical toxicologist or poison control for expert recommendations is recommended. The mainstay of treatment is supportive care. The patient&#x02019;s respiratory and mental status should be assessed. Endotracheal intubation should be performed if there is airway compromise. Massive volume depletion should be anticipated, with replacement utilizing isotonic crystalloid solutions. Blood products may be indicated in cases of hemolysis secondary to stibine exposure. Renal status, urinary output, electrolyte levels, and hepatic function should be closely monitored.<xref ref-type="bibr" rid="article-147467.r6">[6]</xref> Antiemetics may be used for symptomatic control. Official management guidelines have not been formally established, given the low incidence of antimony toxicity.</p>
        <p>Decontamination in the setting of acute toxicity should be considered and performed in a timely manner. Dermal exposures to antimony compounds should be irrigated with soap and water. In acute ingestion, gastric lavage is reasonable to perform. Activated charcoal may theoretically absorb antimony compounds, and multiple doses may be required given the high degree of enterohepatic circulation of antimony if the patient can tolerate administration.<xref ref-type="bibr" rid="article-147467.r71">[71]</xref> Whole bowel irrigation is recommended in severe ingestion based on the patient's tolerance.&#x000a0;The irrigation should be performed within 48 hours based on reports of arsenic poisoning and antimony&#x02019;s similar chemical properties and toxicologic manifestations.<xref ref-type="bibr" rid="article-147467.r72">[72]</xref> If gastrointestinal burns secondary to antimony pentachloride exposure are suspected, esophagogastroduodenoscopy performed by gastroenterology is indicated. Hemodialysis is indicated in the oliguric phase of acute toxicity with renal injury.<xref ref-type="bibr" rid="article-147467.r6">[6]</xref></p>
        <p>Stibine exposure should be managed with prompt removal from the exposure area while employing appropriate safety precautions for rescuers. Administration of high-flow supplemental oxygen should occur after removal. In theory, exchange transfusion may be beneficial for removing the hemoglobin-stibine complex but cannot be routinely recommended due to insufficient data.<xref ref-type="bibr" rid="article-147467.r45">[45]</xref></p>
        <p>Animal experimentation demonstrated improved survival in the chelation of antimony with dimercaprol, succimer, and dimercaptopropane-sulfonic acid (DMPS), with the most effective treatments being succimer and DMPS.<xref ref-type="bibr" rid="article-147467.r73">[73]</xref><xref ref-type="bibr" rid="article-147467.r74">[74]</xref> However, human data is limited given the rarity of antimony toxicity, with a small subset receiving chelation treatment. Some small human study results have shown increased survival after the administration of dimercaprol.<xref ref-type="bibr" rid="article-147467.r71">[71]</xref> Administering intramuscular dimercaprol may be practical until antimony is removed from the gastrointestinal tract, after which transitioning to oral succimer is advisable. Chelation should be ceased if respiratory symptoms with electrocardiogram changes occur.<xref ref-type="bibr" rid="article-147467.r6">[6]</xref> Chelation dosage in the antimony toxicity setting has not been established. The administration of effective dosages for arsenic and other similar metals is reasonable.</p>
        <p>Managing antimony toxicity requires an interdisciplinary approach involving primary care or emergency medicine clinicians alongside a medical toxicologist.&#x000a0;Occupational health specialists may be involved if toxicity is due to occupational exposure. Depending on the affected organ systems, consultants may include ophthalmologists, gastroenterologists, nephrologists, hematologists, pulmonologists, cardiologists, dermatologists, oncologists, endocrinologists, and neurologists.</p>
      </sec>
      <sec id="article-147467.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>In the acute setting, concomitant ingestion and accompanying exposure to other toxic agents must be considered. Antimony toxicity may mimic presentations of other heavy metal poisoning such as arsenic, aluminum, barium, bismuth, cadmium, chromium, cobalt, copper, gold, iron, lead, lithium, manganese, mercury, nickel, phosphorus, selenium, silver, thallium, tin, and zinc. Accompanying exposure to other heavy metals may also be present. Careful history-taking and knowledge of routes of exposure may help differentiate. Serum, urine, and hair levels of other heavy metals may also be obtainable.</p>
      </sec>
      <sec id="article-147467.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of antimony toxicity is mostly dependent on the degree of exposure and clinical manifestations. There has been an observed increase in lung cancer-related deaths in workers exposed to antimony compounds.<xref ref-type="bibr" rid="article-147467.r11">[11]</xref> Mortality may also be seen in patients with massive hemolysis, acute renal failure, acute respiratory failure, and acute hepatic failure.</p>
      </sec>
      <sec id="article-147467.s11" sec-type="Complications">
        <title>Complications</title>
        <p>There are many complications of antimony toxicity given its effect on multiple organ systems. Perhaps the most deadly include life-threatening arrythmia, massive hemolysis, acute respiratory failure, acute renal failure, and acute hepatic failure. Patients have also expired due to sepsis secondary to pancreatitis. Antimony may also lead to permanent ophthalmic, pulmonary, and neurological changes. In addition, patients may have sequelae of malignancies associated with antimony exposure.</p>
      </sec>
      <sec id="article-147467.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Multiple organizations have set antimony exposure limits for workplace environments. The Occupational Health and Safety Administration has set a legal airborne possible exposure limit of 0.5 mg/m<sup>3</sup> averaged over an 8-hour shift, while the National Institute for Occupational Safety and Health has a recommended exposure limit of 0.5 mg/m<sup>3</sup> for antimony and 0.1 mg/m<sup>3</sup> for stibine averaged over a 10-hour shift.<xref ref-type="bibr" rid="article-147467.r11">[11]</xref>&#x000a0;Workplace controls such as labeling containers, providing education on potential hazards, monitoring airborne antimony concentrations, providing emergency showers and eye wash fountains, requiring employees to shower at the end of their shift and avoid taking clothing that may be contaminated home, and good hand washing practices are recommended. Employees should be encouraged to use personal protective equipment, including gloves and clothing that cannot be permeated by antimony compounds, direct vent goggles, and respirators when potential exposure over 0.5 mg/m<sup>3</sup> is present.<xref ref-type="bibr" rid="article-147467.r75">[75]</xref>&#x000a0;In situations of exposure, patients should be removed from the area of exposure, remove contaminated clothing, remove contact lenses, and flush their eyes. Bystanders should be prepared to start artificial respiration and cardiopulmonary resuscitation if necessary. Prompt transfer to a medical facility should be arranged.</p>
      </sec>
      <sec id="article-147467.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The approach and prevention of antimony toxicity should be taken in a collaborative effort among various healthcare professionals. Primary care and occupational and preventative medicine clinicians should educate patients who are at risk of antimony exposure about the proper use of personal protective equipment and preventative measures. Primary care clinicians should also be aware of the symptoms and signs concerning chronic antimony toxicity. Providers administering antimonial compounds for medicinal purposes must be cognizant of the potential adverse events of such treatments. Emergency medicine healthcare professionals should be aware of manifestations of acute toxicity.</p>
        <p>Specialists such as ophthalmologists, gastroenterologists, nephrologists, hematologists, pulmonologists, cardiologists, dermatologists, oncologists, endocrinologists, and neurologists may also be involved depending on affected organ systems. Medical toxicologists and poison control centers should be consulted for expert advice. Communication and knowledge sharing between individuals should be clear and respectful. By ensuring high-quality communication and corroborative effort among various members of the healthcare team, patients will have higher-quality care and more favorable outcomes.</p>
      </sec>
      <sec id="article-147467.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=147467&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=147467">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/wilderness-and-environmental/antimony-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=147467">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/147467/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=147467">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-147467.s15">
        <title>References</title>
        <ref id="article-147467.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Periferakis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Caruntu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Periferakis</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Scheau</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Badarau</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Caruntu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scheau</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Availability, Toxicology and Medical Significance of Antimony.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2022</year>
            <month>Apr</month>
            <day>12</day>
            <volume>19</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">35457536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Kaff</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al-Rajhi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tabbara</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>El-Yazigi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Kohl - the traditional eyeliner: Use and analysis.</article-title>
            <source>Ann Saudi Med</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-30</page-range>
            <pub-id pub-id-type="pmid">17587986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winship</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Toxicity of antimony and its compounds.</article-title>
            <source>Adverse Drug React Acute Poisoning Rev</source>
            <year>1987</year>
            <season>Summer</season>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>67</fpage>
            <page-range>67-90</page-range>
            <pub-id pub-id-type="pmid">3307336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brieger</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic conflicts and the American medical profession in the 1860's.</article-title>
            <source>Bull Hist Med</source>
            <year>1967</year>
            <season>May-Jun</season>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>215</fpage>
            <page-range>215-22</page-range>
            <pub-id pub-id-type="pmid">5343097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haller</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>The use and abuse of tartar emetic in the 19th-century materia medica.</article-title>
            <source>Bull Hist Med</source>
            <year>1975</year>
            <season>Summer</season>
            <volume>49</volume>
            <issue>2</issue>
            <fpage>235</fpage>
            <page-range>235-57</page-range>
            <pub-id pub-id-type="pmid">1100152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mac&#x000ed;as Konstantopoulos</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Burns Ewald</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pratt</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Case records of the Massachusetts General Hospital. Case 22-2012. A 34-year-old man with intractable vomiting after ingestion of an unknown substance.</article-title>
            <source>N Engl J Med</source>
            <year>2012</year>
            <month>Jul</month>
            <day>19</day>
            <volume>367</volume>
            <issue>3</issue>
            <fpage>259</fpage>
            <page-range>259-68</page-range>
            <pub-id pub-id-type="pmid">22808962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarabar</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Antimony toxicity from the use of tartar emetic for the treatment of alcohol abuse.</article-title>
            <source>Vet Hum Toxicol</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>331</fpage>
            <page-range>331-3</page-range>
            <pub-id pub-id-type="pmid">15587254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baiocco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Colotti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Franceschini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ilari</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Molecular basis of antimony treatment in leishmaniasis.</article-title>
            <source>J Med Chem</source>
            <year>2009</year>
            <month>Apr</month>
            <day>23</day>
            <volume>52</volume>
            <issue>8</issue>
            <fpage>2603</fpage>
            <page-range>2603-12</page-range>
            <pub-id pub-id-type="pmid">19317451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mishra</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Kale</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Tiwari</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>Alkaloids: future prospective to combat leishmaniasis.</article-title>
            <source>Fitoterapia</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>80</volume>
            <issue>2</issue>
            <fpage>81</fpage>
            <page-range>81-90</page-range>
            <pub-id pub-id-type="pmid">19015012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>One-step synthesis and flame retardancy of sheaf-like microcrystal antimony oxychloride.</article-title>
            <source>J Nanosci Nanotechnol</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>11</volume>
            <issue>10</issue>
            <fpage>8504</fpage>
            <page-range>8504-9</page-range>
            <pub-id pub-id-type="pmid">22400215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r11">
          <label>11</label>
          <element-citation publication-type="book">
            <source>Toxicological Profile for Antimony and Compounds</source>
            <publisher-name>Agency for Toxic Substances and Disease Registry (US)</publisher-name>
            <publisher-loc>Atlanta (GA)</publisher-loc>
            <year>2019</year>
            <month>10</month>
            <pub-id pub-id-type="pmid">37184169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laporte-Saumure</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mercier</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Characterization and metal availability of copper, lead, antimony and zinc contamination at four Canadian small arms firing ranges.</article-title>
            <source>Environ Technol</source>
            <year>2011</year>
            <season>May-Jun</season>
            <volume>32</volume>
            <issue>7-8</issue>
            <fpage>767</fpage>
            <page-range>767-81</page-range>
            <pub-id pub-id-type="pmid">21879552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>He</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Antimony pollution in China.</article-title>
            <source>Sci Total Environ</source>
            <year>2012</year>
            <month>Apr</month>
            <day>01</day>
            <volume>421-422</volume>
            <fpage>41</fpage>
            <page-range>41-50</page-range>
            <pub-id pub-id-type="pmid">21741676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Corns</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Health risk associated with dietary co-exposure to high levels of antimony and arsenic in the world's largest antimony mine area.</article-title>
            <source>Sci Total Environ</source>
            <year>2011</year>
            <month>Aug</month>
            <day>15</day>
            <volume>409</volume>
            <issue>18</issue>
            <fpage>3344</fpage>
            <page-range>3344-51</page-range>
            <pub-id pub-id-type="pmid">21684578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hansen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tsirigotaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bak</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Pergantis</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>St&#x000fc;rup</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gammelgaard</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Elevated antimony concentrations in commercial juices.</article-title>
            <source>J Environ Monit</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>822</fpage>
            <page-range>822-4</page-range>
            <pub-id pub-id-type="pmid">20383361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shotyk</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Krachler</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Contamination of bottled waters with antimony leaching from polyethylene terephthalate (PET) increases upon storage.</article-title>
            <source>Environ Sci Technol</source>
            <year>2007</year>
            <month>Mar</month>
            <day>01</day>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>1560</fpage>
            <page-range>1560-3</page-range>
            <pub-id pub-id-type="pmid">17396641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andrewes</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kitchin</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Plasmid DNA damage caused by stibine and trimethylstibine.</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <year>2004</year>
            <month>Jan</month>
            <day>01</day>
            <volume>194</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-8</page-range>
            <pub-id pub-id-type="pmid">14728978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parish</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Glass</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kimbrough</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Acute arsine posioning in two workers cleaning a clogged drain.</article-title>
            <source>Arch Environ Health</source>
            <year>1979</year>
            <season>Jul-Aug</season>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>224</fpage>
            <page-range>224-7</page-range>
            <pub-id pub-id-type="pmid">475463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ni</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Levels and risk factors of antimony contamination in human hair from an electronic waste recycling area, Guiyu, China.</article-title>
            <source>Environ Sci Pollut Res Int</source>
            <year>2015</year>
            <month>May</month>
            <volume>22</volume>
            <issue>9</issue>
            <fpage>7112</fpage>
            <page-range>7112-9</page-range>
            <pub-id pub-id-type="pmid">25501644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerhardsson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brune</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nordberg</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Wester</surname>
                <given-names>PO</given-names>
              </name>
            </person-group>
            <article-title>Antimony in lung, liver and kidney tissue from deceased smelter workers.</article-title>
            <source>Scand J Work Environ Health</source>
            <year>1982</year>
            <month>Sep</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>201</fpage>
            <page-range>201-8</page-range>
            <pub-id pub-id-type="pmid">7156939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richter</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Bishop</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Swahn</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Tobacco smoke exposure and levels of urinary metals in the U.S. youth and adult population: the National Health and Nutrition Examination Survey (NHANES) 1999-2004.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>6</volume>
            <issue>7</issue>
            <fpage>1930</fpage>
            <page-range>1930-46</page-range>
            <pub-id pub-id-type="pmid">19742163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kassem</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hussein</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Abaza</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sabry</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Optic atrophy following repeated courses of tartar emetic for the treatment of bilharziasis.</article-title>
            <source>Bull Ophthalmol Soc Egypt</source>
            <year>1976</year>
            <volume>69</volume>
            <issue>73</issue>
            <fpage>459</fpage>
            <page-range>459-63</page-range>
            <pub-id pub-id-type="pmid">1031106</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lauwers</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Roelants</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rosseel</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Heyndrickx</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Baute</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Oral antimony intoxications in man.</article-title>
            <source>Crit Care Med</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>324</fpage>
            <page-range>324-6</page-range>
            <pub-id pub-id-type="pmid">2302961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Lalla</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pellizzer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gradoni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vespignani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Franzetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stecca</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.</article-title>
            <source>Clin Infect Dis</source>
            <year>1993</year>
            <month>May</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>730</fpage>
            <page-range>730-1</page-range>
            <pub-id pub-id-type="pmid">8507769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gasser</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Magill</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Oster</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Franke</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Gr&#x000f6;gl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Berman</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.</article-title>
            <source>Clin Infect Dis</source>
            <year>1994</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <page-range>83-90</page-range>
            <pub-id pub-id-type="pmid">7519887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delgado</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mac&#x000ed;as</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pineda</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Corzo</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Moreno</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>de la Rosa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Quijano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lissen</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>1999</year>
            <month>Nov</month>
            <volume>61</volume>
            <issue>5</issue>
            <fpage>766</fpage>
            <page-range>766-9</page-range>
            <pub-id pub-id-type="pmid">10586909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cotton</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Logan</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Effects of antimony on the cardiovascular system and intestinal smooth muscle.</article-title>
            <source>J Pharmacol Exp Ther</source>
            <year>1966</year>
            <month>Jan</month>
            <volume>151</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-22</page-range>
            <pub-id pub-id-type="pmid">5902182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuryshev</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wible</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ficker</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents.</article-title>
            <source>Mol Pharmacol</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>1216</fpage>
            <page-range>1216-25</page-range>
            <pub-id pub-id-type="pmid">16418337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chulay</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Mugambi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate).</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>1985</year>
            <month>Jul</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>702</fpage>
            <page-range>702-9</page-range>
            <pub-id pub-id-type="pmid">2992303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ortega-Carnicer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alc&#x000e1;zar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>De la Torre</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benezet</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pentavalent antimonial-induced torsade de pointes.</article-title>
            <source>J Electrocardiol</source>
            <year>1997</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-5</page-range>
            <pub-id pub-id-type="pmid">9141610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jo</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>An</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Electrocardiogram abnormalities in antimony exposed workers in the automotive brake lining manufacturing industry: a case report.</article-title>
            <source>Ann Occup Environ Med</source>
            <year>2022</year>
            <volume>34</volume>
            <fpage>e16</fpage>
            <pub-id pub-id-type="pmid">35923793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Electrocardiographic changes occurring after brief antimony administration in the presence of dilated cardiomyopathy.</article-title>
            <source>Postgrad Med J</source>
            <year>1990</year>
            <month>Dec</month>
            <volume>66</volume>
            <issue>782</issue>
            <fpage>1089</fpage>
            <pub-id pub-id-type="pmid">1964735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eryilmaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Durdu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yi&#x0011f;it</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>A case with two unusual findings: cutaneous leishmaniasis presenting as panniculitis and pericarditis after antimony therapy.</article-title>
            <source>Int J Dermatol</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>295</fpage>
            <page-range>295-7</page-range>
            <pub-id pub-id-type="pmid">20465667</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sundar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chakravarty</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Antimony toxicity.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>12</issue>
            <fpage>4267</fpage>
            <page-range>4267-77</page-range>
            <pub-id pub-id-type="pmid">21318007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bentley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Combined exposure to multiple metals on cardiovascular disease in NHANES under five statistical models.</article-title>
            <source>Environ Res</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>215</volume>
            <issue>Pt 3</issue>
            <fpage>114435</fpage>
            <pub-id pub-id-type="pmid">36174761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>RENES</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Antimony poisoning in industry.</article-title>
            <source>AMA Arch Ind Hyg Occup Med</source>
            <year>1953</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>99</fpage>
            <page-range>99-108</page-range>
            <pub-id pub-id-type="pmid">13007205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cordasco</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Newer concepts in the management of environmental pulmonary edema.</article-title>
            <source>Angiology</source>
            <year>1974</year>
            <month>Oct</month>
            <volume>25</volume>
            <issue>9</issue>
            <fpage>590</fpage>
            <page-range>590-601</page-range>
            <pub-id pub-id-type="pmid">4611283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Pendergrass</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Vorwald</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Mayock</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Brieger</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pneumoconiosis among workers in an antimony industry.</article-title>
            <source>Am J Roentgenol Radium Ther Nucl Med</source>
            <year>1968</year>
            <month>Jul</month>
            <volume>103</volume>
            <issue>3</issue>
            <fpage>496</fpage>
            <page-range>496-508</page-range>
            <pub-id pub-id-type="pmid">5659960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Potkonjak</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pavlovich</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Antimoniosis: a particular form of pneumoconiosis. I. Etiology, clinical and X-ray findings.</article-title>
            <source>Int Arch Occup Environ Health</source>
            <year>1983</year>
            <volume>51</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-207</page-range>
            <pub-id pub-id-type="pmid">6222000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balzan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fenech</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Acute renal failure in visceral leishmaniasis treated with sodium stibogluconate.</article-title>
            <source>Trans R Soc Trop Med Hyg</source>
            <year>1992</year>
            <season>Sep-Oct</season>
            <volume>86</volume>
            <issue>5</issue>
            <fpage>515</fpage>
            <page-range>515-6</page-range>
            <pub-id pub-id-type="pmid">1335622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horber</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Lerut</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jaeger</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Renal tubular acidosis, a side effect of treatment with pentavalent antimony.</article-title>
            <source>Clin Nephrol</source>
            <year>1991</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>213</fpage>
            <pub-id pub-id-type="pmid">1659961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rai</surname>
                <given-names>US</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Amitabh</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Acute renal failure and 9th, 10th nerve palsy in patient of kala-azar treated with stibanate.</article-title>
            <source>J Assoc Physicians India</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>338</fpage>
            <pub-id pub-id-type="pmid">7860562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marie</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gehanno</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Bubenheim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Duval-Modeste</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dominique</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bravard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>No&#x000eb;l</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cailleux</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Benichou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Levesque</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Goull&#x000e9;</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Systemic sclerosis and exposure to heavy metals: A case control study of 100 patients and 300 controls.</article-title>
            <source>Autoimmun Rev</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>223</fpage>
            <page-range>223-230</page-range>
            <pub-id pub-id-type="pmid">28137480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vikrant</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kaushal</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Sodium stibogluconate-associated acute interstitial nephritis in a patient treated for visceral leishmaniasis.</article-title>
            <source>Saudi J Kidney Dis Transpl</source>
            <year>2015</year>
            <season>Jul-Aug</season>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>757</fpage>
            <page-range>757-60</page-range>
            <pub-id pub-id-type="pmid">26178551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Romeo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Apostoli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kovacic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brugnone</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Acute arsine intoxication as a consequence of metal burnishing operations.</article-title>
            <source>Am J Ind Med</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-6</page-range>
            <pub-id pub-id-type="pmid">9219649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliveira</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Brustoloni</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Dorval</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cunha</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>B&#x000f3;ia</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil.</article-title>
            <source>Trop Doct</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>180</fpage>
            <page-range>180-2</page-range>
            <pub-id pub-id-type="pmid">19535762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baranwal</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Ravi</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Post-treatment fulminant hepatic failure in an infant with Visceral leishmaniasis: Immune injury or stibogluconate toxicity?</article-title>
            <source>Indian J Pediatr</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>77</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-8</page-range>
            <pub-id pub-id-type="pmid">19936650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>di Martino</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vajro</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nocerino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scotti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Napolitano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vegnente</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Fulminant hepatitis in an Italian infant with visceral leishmaniasis.</article-title>
            <source>Trans R Soc Trop Med Hyg</source>
            <year>1992</year>
            <season>Jan-Feb</season>
            <volume>86</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <pub-id pub-id-type="pmid">1566298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kato</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Morais-Teixeira</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Reis</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Silva-Barcellos</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Sala&#x000fc;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Campos</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Dias Corr&#x000ea;a-Junior</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rabello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Demicheli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fr&#x000e9;zard</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2014</year>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>481</fpage>
            <page-range>481-8</page-range>
            <pub-id pub-id-type="pmid">24189251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mallick</surname>
                <given-names>BK</given-names>
              </name>
            </person-group>
            <article-title>Hypoplasia of bone marrow secondary to sodium antimony gluconate.</article-title>
            <source>J Assoc Physicians India</source>
            <year>1990</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>310</fpage>
            <page-range>310-1</page-range>
            <pub-id pub-id-type="pmid">2167887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pollack</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nagler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liberman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Oren</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Alroy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schechter</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Immunological studies of pancytopenia in visceral leishmaniasis.</article-title>
            <source>Isr J Med Sci</source>
            <year>1988</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>70</fpage>
            <page-range>70-4</page-range>
            <pub-id pub-id-type="pmid">2833465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winski</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Barber</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Rael</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Sequence of toxic events in arsine-induced hemolysis in vitro: implications for the mechanism of toxicity in human erythrocytes.</article-title>
            <source>Fundam Appl Toxicol</source>
            <year>1997</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-8</page-range>
            <pub-id pub-id-type="pmid">9299185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brummitt</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Herwaldt</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>Reversible peripheral neuropathy associated with sodium stibogluconate therapy for American cutaneous leishmaniasis.</article-title>
            <source>Clin Infect Dis</source>
            <year>1996</year>
            <month>May</month>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>878</fpage>
            <page-range>878-9</page-range>
            <pub-id pub-id-type="pmid">8722966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khalil</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Musa</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hussein</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Antimony-induced cerebellar ataxia.</article-title>
            <source>Saudi Med J</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>90</fpage>
            <page-range>90-2</page-range>
            <pub-id pub-id-type="pmid">16432602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Valete-Rosalino</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Araujo-Melo</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Bezerra</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Barcelos</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Melo-Ferreira</surname>
                <given-names>Vd</given-names>
              </name>
              <name>
                <surname>Torraca</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Moreira</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Vargas</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Braga</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Salgueiro</surname>
                <given-names>Mde M</given-names>
              </name>
              <name>
                <surname>Saheki</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Schubach</surname>
                <given-names>AO</given-names>
              </name>
            </person-group>
            <article-title>First report on ototoxicity of meglumine antimoniate.</article-title>
            <source>Rev Inst Med Trop Sao Paulo</source>
            <year>2014</year>
            <season>Sep-Oct</season>
            <volume>56</volume>
            <issue>5</issue>
            <fpage>439</fpage>
            <page-range>439-42</page-range>
            <pub-id pub-id-type="pmid">25229226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maristany Bosch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cuervo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Matas Mart&#x000ed;n</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Veciana de Las Heras</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pedro P&#x000e9;rez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez Y&#x000e9;lamos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sab&#x000e9; Fern&#x000e1;ndez</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Neurological toxicity due to antimonial treatment for refractory visceral leishmaniasis.</article-title>
            <source>Clin Neurophysiol Pract</source>
            <year>2021</year>
            <volume>6</volume>
            <fpage>164</fpage>
            <page-range>164-167</page-range>
            <pub-id pub-id-type="pmid">35112035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grosskopf</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schwerdtle</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mullenders</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Hartwig</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Antimony impairs nucleotide excision repair: XPA and XPE as potential molecular targets.</article-title>
            <source>Chem Res Toxicol</source>
            <year>2010</year>
            <month>Jul</month>
            <day>19</day>
            <volume>23</volume>
            <issue>7</issue>
            <fpage>1175</fpage>
            <page-range>1175-83</page-range>
            <pub-id pub-id-type="pmid">20509621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Groth</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Stettler</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Burg</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Busey</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Carcinogenic effects of antimony trioxide and antimony ore concentrate in rats.</article-title>
            <source>J Toxicol Environ Health</source>
            <year>1986</year>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>607</fpage>
            <page-range>607-26</page-range>
            <pub-id pub-id-type="pmid">3735460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Survey of antimony workers: mortality 1961-1992.</article-title>
            <source>Occup Environ Med</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>51</volume>
            <issue>11</issue>
            <fpage>772</fpage>
            <page-range>772-6</page-range>
            <pub-id pub-id-type="pmid">7849856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lou</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Antimony exposure promotes bladder tumor cell growth by inhibiting PINK1-Parkin-mediated mitophagy.</article-title>
            <source>Ecotoxicol Environ Saf</source>
            <year>2021</year>
            <month>Sep</month>
            <day>15</day>
            <volume>221</volume>
            <fpage>112420</fpage>
            <pub-id pub-id-type="pmid">34166935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Low-dose antimony exposure promotes prostate cancer proliferation by inhibiting ferroptosis via activation of the Nrf2-SLC7A11-GPX4 pathway.</article-title>
            <source>Chemosphere</source>
            <year>2023</year>
            <month>Oct</month>
            <volume>339</volume>
            <fpage>139716</fpage>
            <pub-id pub-id-type="pmid">37562508</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>GELLHORN</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>TUPIKOVA</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>VAN DYKE</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>The tissue-distribution and excretion of four organic antimonials after single or repeated administration to normal hamsters.</article-title>
            <source>J Pharmacol Exp Ther</source>
            <year>1946</year>
            <month>Jun</month>
            <volume>87</volume>
            <fpage>169</fpage>
            <page-range>169-80</page-range>
            <pub-id pub-id-type="pmid">20989229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waitz</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ober</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Meisenhelder</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Physiological disposition of antimony after administration of 124Sb-labelled tartar emetic to rats, mice and monkeys, and the effects of tris (p-aminophenyl) Carbonium pamoate on this distribution.</article-title>
            <source>Bull World Health Organ</source>
            <year>1965</year>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>537</fpage>
            <page-range>537-46</page-range>
            <pub-id pub-id-type="pmid">5294998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DJURIC</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>THOMAS</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>LIE</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The distribution and excretion of trivalent antimony in the rat following inhalation.</article-title>
            <source>Int Arch Gewerbepathol Gewerbehyg</source>
            <year>1962</year>
            <month>Oct</month>
            <day>05</day>
            <volume>19</volume>
            <fpage>529</fpage>
            <page-range>529-45</page-range>
            <pub-id pub-id-type="pmid">14028162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sala&#x000fc;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fr&#x000e9;zard</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Unexpectedly high levels of antimony (III) in the pentavalent antimonial drug Glucantime: insights from a new voltammetric approach.</article-title>
            <source>Anal Bioanal Chem</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>405</volume>
            <issue>15</issue>
            <fpage>5201</fpage>
            <page-range>5201-14</page-range>
            <pub-id pub-id-type="pmid">23612869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevenson</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Antimony spots.</article-title>
            <source>Trans St Johns Hosp Dermatol Soc</source>
            <year>1965</year>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-8</page-range>
            <pub-id pub-id-type="pmid">4220643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Motolese</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Truzzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Giannini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Seidenari</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Contact dermatitis and contact sensitization among enamellers and decorators in the ceramics industry.</article-title>
            <source>Contact Dermatitis</source>
            <year>1993</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>59</fpage>
            <page-range>59-62</page-range>
            <pub-id pub-id-type="pmid">8458219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buchanan</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Eberhardt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tebb</surname>
                <given-names>ZD</given-names>
              </name>
              <name>
                <surname>Heard</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wendlandt</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Kosnett</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Massive human ingestion of orpiment (arsenic trisulfide).</article-title>
            <source>J Emerg Med</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>367</fpage>
            <page-range>367-72</page-range>
            <pub-id pub-id-type="pmid">22541879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mansour</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Rassoul</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Schulert</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Anti-bilharzial antimony drugs.</article-title>
            <source>Nature</source>
            <year>1967</year>
            <month>May</month>
            <day>20</day>
            <volume>214</volume>
            <issue>5090</issue>
            <fpage>819</fpage>
            <page-range>819-20</page-range>
            <pub-id pub-id-type="pmid">6051866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paschal</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Ting</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Pirkle</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Caldwell</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Trace metals in urine of United States residents: reference range concentrations.</article-title>
            <source>Environ Res</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>76</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-9</page-range>
            <pub-id pub-id-type="pmid">9466897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bailly</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lauwerys</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Buchet</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Mahieu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Konings</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Experimental and human studies on antimony metabolism: their relevance for the biological monitoring of workers exposed to inorganic antimony.</article-title>
            <source>Br J Ind Med</source>
            <year>1991</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-7</page-range>
            <pub-id pub-id-type="pmid">1998614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Isbister</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Whyte</surname>
                <given-names>IM</given-names>
              </name>
            </person-group>
            <article-title>Arsenic trioxide poisoning: a description of two acute overdoses.</article-title>
            <source>Hum Exp Toxicol</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>23</volume>
            <issue>7</issue>
            <fpage>359</fpage>
            <page-range>359-64</page-range>
            <pub-id pub-id-type="pmid">15311855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basinger</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Structural requirements for chelate antidotal efficacy in acute antimony(III) intoxication.</article-title>
            <source>Res Commun Chem Pathol Pharmacol</source>
            <year>1981</year>
            <month>May</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>355</fpage>
            <page-range>355-63</page-range>
            <pub-id pub-id-type="pmid">6264554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hruby</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Donner</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>2,3-Dimercapto-1-propanesulphonate in heavy metal poisoning.</article-title>
            <source>Med Toxicol Adverse Drug Exp</source>
            <year>1987</year>
            <season>Sep-Oct</season>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>317</fpage>
            <page-range>317-23</page-range>
            <pub-id pub-id-type="pmid">3312928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147467.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schildroth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Osborne</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Yip</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Sandy</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Occupational exposure to antimony trioxide: a risk assessment.</article-title>
            <source>Occup Environ Med</source>
            <year>2020</year>
            <month>Nov</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">33243757</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
